ArticlePharmaceutics2022

Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis.

Rima El-Dirany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.